Polypill Eligibility for Patients with Heart Failure with Reduced Ejection Fraction in the ASIAN-HF Registry: A Cross-Sectional Analysis
References
- Teng THK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, et al. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. Lancet Global Heal. 2018; 6(9): e1008–e1018. DOI: 10.1016/S2214-109X(18)30306-1
- McMurray JJ, Packer M. How should we sequence the treatments for heart failure and a reduced ejection fraction? A redefinition of evidence-based medicine. Circulation. 2021; 143(9): 875–877. DOI: 10.1161/CIRCULATIONAHA.120.052926
- Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145(18): e895–e1032. DOI: 10.1161/CIR.0000000000001063
- Greene SJ, Butler J, Fonarow GC. Simultaneous or rapid sequence initiation of quadruple medical therapy for heart failure—optimizing therapy with the need for speed. JAMA Cardiol. 2021; 6(7). DOI: 10.1001/jamacardio.2021.0496
- Agarwal A, Yancy CW, Huffman MD. Improving care for heart failure with reduced ejection fraction—A potential polypill-based strategy. JAMA. 2020; 324(22): 2259–2260. DOI: 10.1001/jama.2020.21395
- Lam CSP, Anand I, Zhang S, Shimizu W, Narasimhan C, Park SW, et al. Asian sudden cardiac death in heart failure (ASIAN-HF) registry. Eur J Heart Fail. 2013; 15(8): 928–936. DOI: 10.1093/eurjhf/hft045
- Lam CSP, Teng THK, Tay WT, Anand I, Zhang S, Shimizu W, et al. Regional and ethnic differences among patients with heart failure in Asia: The Asian sudden cardiac death in heart failure registry. Eur Heart J. 2016; 37(41): 3141–3153. DOI: 10.1093/eurheartj/ehw331
- Rosano GMC, Moura B, Metra M, Böhm M, Bauersachs J, Ben Gal T, et al. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2021; 23(6): 872–881. DOI: 10.1002/ejhf.2206
- Vijay A, Mohanan PP, Kondal D, Baldridge A, Davies D, Devarajan R, et al. Polypill eligibility for patients with heart failure with reduced ejection fraction in South India: A secondary analysis of a prospective, interrupted time series study. J Am Heart Assoc. 2021; 10(20):
e021676 . DOI: 10.1161/JAHA.121.021676 - Santema BT, Ouwerkerk W, Tromp J, Sama IE, Ravera A, Regitz-Zagrosek V, et al. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study. Lancet. 2019; 394(10205): 1254–1263. DOI: 10.1016/S0140-6736(19)31792-1
- Bahiru E, Cates AN de, Farr MR, Jarvis MC, Palla M, Rees K, et al. Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Db Syst Rev. 2017; 3. DOI: 10.1002/14651858.CD009868.pub3
DOI: https://doi.org/10.5334/gh.1215 | Journal eISSN: 2211-8179
Language: English
Submitted on: Feb 28, 2023
Accepted on: May 26, 2023
Published on: Jun 15, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Aishwarya Vijay, Wan Ting Tay, Tiew-Hwa K. Teng, Kanako Teramoto, Jasper Tromp, Wouter Ouwerkerk, Seet Yoong Lo, Wataru Shimizu, Mark D. Huffman, Carolyn S. P. Lam, Chanchal Chandramouli, Anubha Agarwal, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.